AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
MIDAZOLAM
86 registrations across 12 African markets— 62 active
Markets with MIDAZOLAM
🇿🇦South Africa
34 registrations
24 active
🇹🇳Tunisia
11 registrations
0 active
🇲🇦Morocco
10 registrations
10 active
🇬🇭Ghana
8 registrations
8 active
🇸🇳Senegal
6 registrations
6 active
🇨🇮Côte d'Ivoire
5 registrations
3 active
🇺🇬Uganda
4 registrations
4 active
🇹🇿Tanzania
3 registrations
3 active
🇲🇬Madagascar
2 registrations
2 active
🇲🇼Malawi
1 registration
0 active
🇿🇲Zambia
1 registration
1 active
🇿🇼Zimbabwe
1 registration
1 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Benzosed Solution for Injection | 🇿🇲Zambia | Troikaa Pharmaceuticals Ltd | active | May 2031 |
| Midazolam 1mg/ml Injection (Each ampoule contains Midazolam 1mg/ml) | 🇬🇭Ghana | — | active | May 2031 |
| Midazolam 1mg/ml Injection (Each ampoule contains Midazolam 1mg/ml) | 🇬🇭Ghana | — | active | May 2031 |
| MEZOLAM SOLUTION; INJECTION | 🇿🇼Zimbabwe | ARAVAS PHARMACEUTICALS | active | Nov 2030 |
| MIDAZBIL INJECTION (Each 3ml ampoule contains Midazolam 5mg/ml) | 🇬🇭Ghana | — | active | Sept 2030 |
| MIDAZBIL INJECTION (Each 3ml ampoule contains Midazolam 5mg/ml) | 🇬🇭Ghana | — | active | Sept 2030 |
| DORMICUM 5MG/5ML AMPOULES (Each 5ml contains Midazolam 5mg) | 🇬🇭Ghana | — | active | May 2030 |
| DORMICUM 5MG/5ML AMPOULES (Each 5ml contains Midazolam 5mg) | 🇬🇭Ghana | — | active | May 2030 |
| MIDAVER INJECTION (Each Injection contains Midazolam 1mg) | 🇬🇭Ghana | — | active | May 2029 |
| MIDAVER INJECTION (Each Injection contains Midazolam 1mg) | 🇬🇭Ghana | — | active | May 2029 |
| MIDAZOLAM 5 mg NASAL SPRAY CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Feb 2029 |
| MIRANOST | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Feb 2029 |
| MIDANIUM 15 mg/3 ML | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| MIDANIUM 5 mg/5 ML | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| MIDAZOLAM-CP 15 mg/3 ML | 🇿🇦South Africa | Pharmaplan (Pty) Ltd | suspended | Dec 2023 |
| MIDAZOLAM-CP 5 mg/5 ML | 🇿🇦South Africa | Pharmaplan (Pty) Ltd | suspended | Dec 2023 |
| MIDAZOLAM-CP 50 mg/10 ML | 🇿🇦South Africa | Pharmaplan (Pty) Ltd | suspended | Dec 2023 |
| MIDAZOLAM STERIPHARM Solution injectable / 25 mg/5 ml | 🇹🇳Tunisia | STERIPHARM | expired | Jul 2023 |
| MIDAZOLAM STERIPHARM Solution injectable / 5 mg/ml | 🇹🇳Tunisia | STERIPHARM | expired | Jul 2023 |
| MIZAM 5 mg/ml (5 ml) | 🇿🇦South Africa | Biotech Laboratories (Pty) Ltd | suspended | Jan 2023 |
| MIZAM 1 mg/ml (5 ml) | 🇿🇦South Africa | Biotech Laboratories (Pty) Ltd | suspended | Jan 2023 |
| MIZAM 5 mg/ml (10 ml) | 🇿🇦South Africa | Biotech Laboratories (Pty) Ltd | suspended | Jan 2023 |
| MIDAZOLAM B BRAUN 5 mg/ml | 🇿🇦South Africa | B Braun Medical (Pty) Ltd | suspended | Nov 2022 |
| MIDAZOLAM B BRAUN 1 mg/ml | 🇿🇦South Africa | B Braun Medical (Pty) Ltd | suspended | Nov 2022 |
| SEDALAM 15 MG / 3 ML IM / IV SOLUTION INJECTABLE BOITE DE 5 FLACON DE 3 ML | 🇨🇮Côte d'Ivoire | LABORATOIRE MS PHARMA | expired | Jan 2021 |
| SEDALAM 5 MG / 5 ML IM / IV SOLUTION INJECTABLE BOITE DE 10 FLACONS DE 5 ML | 🇨🇮Côte d'Ivoire | LABORATOIRE MS PHARMA | expired | Jan 2021 |
| ZOLAM 5 Solution injectable / 5 mg/ml | 🇹🇳Tunisia | DORCAS | expired | Jul 2015 |
| ZOLAM 25 Solution injectable / 25 mg/5 ml | 🇹🇳Tunisia | DORCAS | expired | Jul 2015 |
| IPNODIS Solution injectable / 50 MG/10ML | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | May 2011 |
| MIDAZOLAM AGUETTANT Solution injectable / 5 mg/ml | 🇹🇳Tunisia | LABORATOIRE AGUETTANT | expired | May 2011 |
| MIDAZOLAM AGUETTANT Solution injectable / 5 mg/ml | 🇹🇳Tunisia | LABORATOIRE AGUETTANT | expired | May 2011 |
| HIKMA MIDAZOLAM Solution injectable / 5 mg/ml | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Nov 2006 |
| IPNODIS MEDIS Solution injectable / 25 mg/5ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Sept 2003 |
| IPNODIS MEDIS Solution injectable / 5 mg/1ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Sept 2003 |
| IPNODIS MEDIS Solution injectable / 2 mg/2ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Sept 2003 |
| DORMICUM 7.5 MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2003 |
| DORMICUM 15 mg/3 ml | 🇿🇦South Africa | Pharmaco Distribution (Pty) Ltd | active | Jan 1900 |
| DORMICUM 50 mg/10 ml* | 🇿🇦South Africa | Pharmaco Distribution (Pty) Ltd | active | Jan 1900 |
| DORMICUM 7,5 mg | 🇿🇦South Africa | Pharmaco Distribution (Pty) Ltd | active | Jan 1900 |
| MIDAZOLAM 50 mg/10 ml PHARMC | 🇿🇦South Africa | Pharmacorp (Pty) Ltd | active | Jan 1900 |
| SABAX MIDAZOLAM INJECTION 50 mg/10 ml | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| ADCO MIDAZOLAM INJECTION 5 mg/5 ml | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| SABAX MIDAZOLAM INJECTION 15 mg/3 ml | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | active | Jan 1900 |
| MIDAZOLAM SPECPHARM 50 mg/10 ml | 🇿🇦South Africa | Specpharm (Pty) Ltd | active | Jan 1900 |
| DORMICUM 5 mg/5 ml | 🇿🇦South Africa | Pharmaco Distribution (Pty) Ltd | active | Jan 1900 |
| MIDAZOLAM HEXAL 5 mg/1 ml BIOTECH | 🇿🇦South Africa | Biotech Laboratories (Pty) Ltd | active | Jan 1900 |
| MIDAZOLAM SPECPHARM 5 mg/5 ml | 🇿🇦South Africa | Specpharm (Pty) Ltd | active | Jan 1900 |
| ZOLAMID 15 mg/3 ML | 🇿🇦South Africa | Dezzo Trading 392 (Pty) Ltd | active | Jan 1900 |
| MIDACUM 5 mg/ml | 🇿🇦South Africa | Oethmaan Biosims (Pty) Ltd | active | Jan 1900 |
| MIDACUM 15 mg/3 ml | 🇿🇦South Africa | Oethmaan Biosims (Pty) Ltd | active | Jan 1900 |
Showing 50 of 86 registrations. Sign up free to search and export all.
MIDAZOLAM in Africa — Regulatory Overview
MIDAZOLAM is registered across 12 African markets with 86 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tunisia, Morocco, Ghana and 8 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 86 registrations, 62 (72%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.